These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6806805)

  • 61. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy].
    Koyama K; Kawakami K; Harada Y; Yamaryo T; Kimura Y
    Kekkaku; 2007 Jul; 82(7):577-81. PubMed ID: 17695788
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Persisters and chemotherapy in tuberculous infection (author's transl)].
    Kanai K
    Kekkaku; 1978 Dec; 53(12):557-67. PubMed ID: 106180
    [No Abstract]   [Full Text] [Related]  

  • 63. [The treatment of tuberculosis. I. Mycobacterial subpopulations in the lesions and antitubercular drugs].
    Corlan E
    Pneumoftiziologia; 1992; 41(4):231-42. PubMed ID: 1339503
    [No Abstract]   [Full Text] [Related]  

  • 64. [Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis].
    Novozhilova IA
    Probl Tuberk Bolezn Legk; 2004; (4):29-31. PubMed ID: 15171041
    [No Abstract]   [Full Text] [Related]  

  • 65. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
    Koretskaia NM; Iarygina IV
    Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Results of antibacterial treatment of patients with bacteriologically confirmed pulmonary tuberculosis in Poland 1982].
    Szczuka I
    Pneumonol Pol; 1984 Sep; 52(9):409-18. PubMed ID: 6442409
    [No Abstract]   [Full Text] [Related]  

  • 67. [Characteristics of the course of pulmonary tuberculosis caused by Mycobacterium bovis].
    Kochetov BI; Dolzhanskiĭ VM; Nemsadze MN
    Probl Tuberk; 1980 Feb; (2):23-6. PubMed ID: 6990406
    [No Abstract]   [Full Text] [Related]  

  • 68. Case 5: presentation. Pulmonary tuberculosis.
    Starke JR
    Paediatr Respir Rev; 2001 Jun; 2(2):196, 199. PubMed ID: 12531074
    [No Abstract]   [Full Text] [Related]  

  • 69. Tuberculosis chemotherapy--how long.
    Lancet; 1979 Jun; 1(8131):1383-4. PubMed ID: 87838
    [No Abstract]   [Full Text] [Related]  

  • 70. [Primary drug resistance in Mycobacterium tuberculosis among patients with pulmonary tuberculosis and its impact on permanent disability in the Volgograd region].
    Borzenko AS; gagarina SG; Samoĭlova IV; Kalushenina AA
    Probl Tuberk Bolezn Legk; 2007; (12):28-30. PubMed ID: 18326212
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Chemotherapy of destructive tuberculosis with the study of the total bacteriostatic activity of the resected lung tissue].
    Kovalenko NN; Ginzburg TS
    Vrach Delo; 1988 Apr; (4):95-6. PubMed ID: 3135669
    [No Abstract]   [Full Text] [Related]  

  • 72. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains].
    Zhukova MP
    Probl Tuberk; 1997; (5):12-5. PubMed ID: 9454239
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
    Irtuganova OA; Smirnova NS; Slogotskaia LV
    Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
    [No Abstract]   [Full Text] [Related]  

  • 74. [Design and study of new agents having antitubercular activity: the original compound perchlosone as a potent agent of etiotropic therapy for tuberculosis].
    Vinogradova TI; Aleksandrova AE; Antonenkova EV; Elokhina VN; Nakhmanovich AS
    Probl Tuberk; 1999; (3):45-7. PubMed ID: 10420769
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Mycobacterium tuberculosis with initial drug resistance in silicotuberculosis and pulmonary tuberculosis patients].
    Beskrovnyĭ PS; Varenko IuS; Revenko TA
    Probl Tuberk; 1982 Mar; (3):68-71. PubMed ID: 6806809
    [No Abstract]   [Full Text] [Related]  

  • 76. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Treatment and outcomes of disseminated pulmonary tuberculosis].
    Rzhavskov IV; Lishchinskii AB; Znosenko VA
    Probl Tuberk; 1997; (1):40-1. PubMed ID: 9162924
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs.
    Ann Pharmacother; 2006 May; 40(5):1007-8. PubMed ID: 16670365
    [No Abstract]   [Full Text] [Related]  

  • 79. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
    Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
    Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Experimental study of therapeutic effect of various antibacterial drug combinations].
    Kozulitsyna TI; Uvarova OA; Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1980 Jul; (7):49-53. PubMed ID: 7413637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.